Article Details
Retrieved on: 2021-05-25 11:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Under the collaboration, AstraZeneca will pay Silence an option fee of $10 million for each selected target at the point of candidate nomination.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here